NextPlat to Release Second Quarter 2025 Results on Thursday, August 14, 2025
Investor Conference Call Scheduled for Thursday, August 14, 2025 at 8:30 a.m. Eastern COCONUT GROVE, Fla., Aug. 6, 2025 /PRNewswire/ — NextPlat Corp (NASDAQ:... Read more.
BV Investment Partners Announces Majority Investment in The Millennium Alliance
BOSTON, Aug. 6, 2025 /PRNewswire/ — BV Investment Partners (BV), a middle-market private equity firm focused on the tech-enabled business services, software... Read more.
MIND Technology Expands Huntsville Facility
THE WOODLANDS, Texas, Aug. 6, 2025 /PRNewswire/ — MIND Technology, Inc. (“MIND” or the “Company”) (Nasdaq: MIND) announced today that... Read more.
JACK HENRY & ASSOCIATES TO PROVIDE WEBCAST OF FOURTH QUARTER FISCAL 2025 EARNINGS CALL
MONETT, Mo., Aug. 6, 2025 /PRNewswire/ — Jack Henry & Associates, Inc.® (NASDAQ: JKHY) announced today that it will host a live Webcast of its fourth... Read more.
United Airlines Takes Equity Stake in Dfinitiv to Advance Commerce Media and Loyalty Program Priorities
Airline’s corporate venture capital fund – United Airlines Ventures (UAV) – facilitates new relationship that leverages Dfinitiv’s proprietary... Read more.
Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors
BRADENTON, Fla., Aug. 6, 2025 /PRNewswire/ — Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced... Read more.
HR Path Strengthens Global Presence with Strategic Acquisition of PredictiveHR
PARIS, Aug. 6, 2025 /PRNewswire/ — HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce its strategic acquisition of PredictiveHR,... Read more.
AML RightSource Named by Everest Group as a Leader in Financial Crime Compliance
CLEVELAND, Aug. 6, 2025 /PRNewswire/ — AML RightSource, the global expert solutions leader in financial crime compliance and third-party risk management, has... Read more.
FDA approves expanded indication for AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in cytokine release syndrome (CRS)
Approval of AVTOZMA® (tocilizumab-anoh) intravenous infusion expands label to include treatment of adults and pediatric patients aged 2 years and older with cytokine... Read more.
New Perspective increases length of stay by nearly 6 months with comprehensive use of LifeLoop
Groundbreaking 15-month research offers senior living’s first quantifiable ROI for engagement technology Download the research study: Quantifying the impact... Read more.